Novel insights into the aetiology of granulomatosis with polyangiitis—a case–control study using the Clinical Practice Research Datalink

Abstract Objectives We aimed to provide insights into the aetiology of granulomatosis with polyangiitis (GPA), by conducting a large case–control study using a general population-based, prospectively collected database of healthcare records. Methods We compared all incident cases of GPA in the Clinical Practice Research Datalink 1990–2014, with up to 10 age-, sex- and general practice-matched controls. We identified potential risk factors, recorded numbers of cases and controls exposed to each, and calculated odds ratios (ORs) using conditional logistic regression. Our main analysis excluded data recorded during 1 year before diagnosis, to prevent early symptoms being mistaken for risk factors. Results We identified 757 people with GPA and matched 7546 controls. People with GPA were five times more likely to have a previous diagnosis of bronchiectasis (OR = 5.1, 95% CI: 2.7, 9.4; P < 0.0001), and these effects remained stable in diagnoses recorded >5 years prior to diagnosis. People with GPA were two to three times more likely than controls to have previous diagnoses of autoimmune diseases or chronic renal impairment, and these effects also remained stable >5 years prior to diagnosis. People with GPA were more likely to have a diagnosis of pulmonary fibrosis (OR = 5.7, 95% CI: 1.7, 19.5; P = 0.01) and sinus infections (OR = 2.7, 95% CI: 1.8, 4.2; P < 0.0001) recorded in the 3 years before diagnosis, but not before this. We also found former smoking, some medications and higher socio-economic status significantly, but less strongly, associated. Conclusion We found novel long-term associations between GPA and pre-existing bronchiectasis and autoimmune diseases.

[1]  Cisca Wijmenga,et al.  The MHC locus and genetic susceptibility to autoimmune and infectious diseases , 2017, Genome Biology.

[2]  Richard A Watts,et al.  The incidence, prevalence and mortality of granulomatosis with polyangiitis in the UK Clinical Practice Research Datalink , 2016, Rheumatology.

[3]  C. Tcherakian,et al.  Antineutrophil cytoplasmic antibodies (ANCA) associated-bronchiectasis appears more severe than “idiopathic” bronchiectasis , 2015 .

[4]  J. Pers,et al.  ANCA-associated vasculitis in patients with primary Sjögren's syndrome: detailed analysis of 7 new cases and systematic literature review. , 2015, Autoimmunity reviews.

[5]  K. Bhaskaran,et al.  Data Resource Profile: Clinical Practice Research Datalink (CPRD) , 2015, International journal of epidemiology.

[6]  C. Théodore,et al.  Successful treatment of antineutrophil cytoplasmic antibody-associated bronchiectasis with immunosuppressive therapy , 2015, European Respiratory Journal.

[7]  David Moher,et al.  The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines , 2015, PloS one.

[8]  A. Mocroft,et al.  Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study , 2015, PLoS medicine.

[9]  A. Salama,et al.  Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome , 2015, SpringerPlus.

[10]  C. Cappi,et al.  An Inherited Small Microdeletion at 15q13.3 in a Patient with Early- Onset Obsessive-Compulsive Disorder , 2014, PloS one.

[11]  T. Neri,et al.  Genetic Susceptibility to ANCA-Associated Vasculitis: State of the Art , 2014, Front. Immunol..

[12]  D. Reeves,et al.  ClinicalCodes: An Online Clinical Codes Repository to Improve the Validity and Reproducibility of Research Using Electronic Medical Records , 2014, PloS one.

[13]  J. Mooney What are the informational needs of patients with ANCA-associated vasculitis? : a mixed methods study , 2014 .

[14]  S. Sacre,et al.  Emerging Role of Endosomal Toll-Like Receptors in Rheumatoid Arthritis , 2013, Front. Immunol..

[15]  C. Denton,et al.  Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors. , 2013, Rheumatology.

[16]  A. Condliffe,et al.  Coexistence of Bronchiectasis and Rheumatoid Arthritis: Revisited , 2013, Respiratory Care.

[17]  J. Anaya,et al.  How do autoimmune diseases cluster in families? A systematic review and meta-analysis , 2013, BMC Medicine.

[18]  K. Siminovitch,et al.  Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis. , 2012, Arthritis and rheumatism.

[19]  Garth L Burn,et al.  Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? , 2011, FEBS letters.

[20]  P. Merkel,et al.  A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis , 2011, Arthritis care & research.

[21]  P. Merkel,et al.  Alpha 1 -Antitrypsin Deficiency–Related Alleles Z and S and the Risk of Wegener’s Granulomatosis , 2011 .

[22]  R. Wilson,et al.  Bronchiectasis and autoimmune disease , 2011 .

[23]  L. Smeeth,et al.  Validation and validity of diagnoses in the General Practice Research Database: a systematic review , 2010, British journal of clinical pharmacology.

[24]  Glinda S Cooper,et al.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. , 2009, Journal of autoimmunity.

[25]  D. Scott,et al.  Prevalence and incidence of Wegener's granulomatosis in the UK general practice research database. , 2009, Arthritis and rheumatism.

[26]  G. Bishop,et al.  CD40 and autoimmunity: the dark side of a great activator. , 2009, Seminars in immunology.

[27]  Irene Petersen,et al.  Creating medical and drug code lists to identify cases in primary care databases , 2009, Pharmacoepidemiology and drug safety.

[28]  K. Scalapino,et al.  CTLA‐4: a key regulatory point in the control of autoimmune disease , 2008, Immunological reviews.

[29]  Emile de Heer,et al.  Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[30]  R. Falk,et al.  Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case-control study. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[32]  L. Stamp,et al.  Wegener’s granulomatosis in New Zealand: evidence for a latitude‐dependent incidence gradient , 2007, Internal medicine journal.

[33]  S. Galandiuk,et al.  Smoking and inflammatory bowel disease: a meta-analysis. , 2006, Mayo Clinic proceedings.

[34]  L. Smeeth,et al.  Autoimmune Diseases Co-occurring Within Individuals and Within Families: A Systematic Review , 2006, Epidemiology.

[35]  Northgate Hospital Episode Statistics , 2006 .

[36]  M. Benucci,et al.  [Bronchiectasis worsening by p-ANCA (bactericidal/permeability-increasing protein) positive vasculitis. A case report and review of the literature]. , 2005, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna.

[37]  M. Haubitz,et al.  Smoking habits in patients diagnosed with ANCA associated small vessel vasculitis , 2005, Annals of the rheumatic diseases.

[38]  W. Bilker,et al.  The relationship between time since registration and measured incidence rates in the General Practice Research Database , 2005, Pharmacoepidemiology and drug safety.

[39]  K. Takahashi,et al.  Development of Microscopic Polyangiitis in Patients with Chronic Airway Disease , 2005, Lung.

[40]  L. Maier Is smoking beneficial for granulomatous lung diseases? , 2004, American journal of respiratory and critical care medicine.

[41]  D. Roos,et al.  Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies. , 2004, Human immunology.

[42]  M. Sopori,et al.  Effects of cigarette smoke on the immune system , 2002, Nature Reviews Immunology.

[43]  S. Pearce,et al.  An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. , 2002, Rheumatology.

[44]  C. Kallenberg,et al.  Staphylococcus aureus and Wegener's granulomatosis , 2001, Arthritis research.

[45]  M. Osame,et al.  Bronchiectasis with myeloperoxidase antineutrophil cytoplasmic antibody and bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibody. , 1999, Internal medicine.

[46]  N. Cary,et al.  Vasculitis and bronchiectasis in a patient with antibodies to bactericidal/permeability-increasing protein and alpha1-antitrypsin deficiency. , 1997, Chest.

[47]  J. Hollowell,et al.  The General Practice Research Database: quality of morbidity data. , 1997, Population trends.

[48]  N. Booth What are the Read Codes? , 1994, Health libraries review.